Drug Pricing Reform Failure is Unacceptable
Drug Prices
Drug Pricing Reform Failure is Unacceptable
Organ Failure: The Urgent Need for Reform
Organ Donation
Organ Failure: The Urgent Need for Reform
Part 3: After a Groundswell of Success in 2021, Stage is Set for Broader Rx Reform in 2022
Drug Prices
Part 3: After a Groundswell of Success in 2021, Stage is Set for Broader Rx Reform in 2022
Part 2: In Quest to Lower Rx Prices, States Deploy New Tools
Drug Prices
Part 2: In Quest to Lower Rx Prices, States Deploy New Tools
Part 1: As Congress Debates Lowering Drug Prices, States Waste No Time
Drug Prices
Part 1: As Congress Debates Lowering Drug Prices, States Waste No Time
Protecting Patients From the Cost of Surprise Billing is Not Finished
Commercial Sector Prices
Protecting Patients From the Cost of Surprise Billing is Not Finished
Any Public Option Design Must Lower Health Care Costs
Commercial Sector Prices
Any Public Option Design Must Lower Health Care Costs
5 Things to Watch for in the Medicare Trustees’ Report
Medicare Sustainability
5 Things to Watch for in the Medicare Trustees’ Report
Biden Takes Aim at Drug Prices with Executive Order. Does it Go Far Enough?
Drug Prices
Biden Takes Aim at Drug Prices with Executive Order. Does it Go Far Enough?
New Poll: Majority of Voters Want Congress To Take Action To Lower Health Care Prices
Commercial Sector Prices
New Poll: Majority of Voters Want Congress To Take Action To Lower Health Care Prices
MACPAC Recommends Policies To Reduce Spending on High Cost Specialty Drugs in the Medicaid Program
Drug Prices
MACPAC Recommends Policies To Reduce Spending on High Cost Specialty Drugs in the Medicaid Program
Part 2: In No Surprises Act, Arbitration Design Is Key to Realizing Expected Savings
Commercial Sector Prices
Part 2: In No Surprises Act, Arbitration Design Is Key to Realizing Expected Savings
Part 1: Fulfilling the Promises of the Surprise Billing Ban
Commercial Sector Prices
Part 1: Fulfilling the Promises of the Surprise Billing Ban
‘It’s Just Simply the Cost Per Dose That Americans Are Being Charged More For’
Drug Prices
‘It’s Just Simply the Cost Per Dose That Americans Are Being Charged More For’
Congress Grills Major Drug Manufacturer on Anticompetitive Tactics and Price Gouging
Drug Prices
Congress Grills Major Drug Manufacturer on Anticompetitive Tactics and Price Gouging
Policies Take Aim at Rising Health Care Costs Hurting Families, Employers and Taxpayers
Commercial Sector Prices
Policies Take Aim at Rising Health Care Costs Hurting Families, Employers and Taxpayers
President Biden Called on Congress to Lower Drug Prices. What’s Next?
Drug Prices
President Biden Called on Congress to Lower Drug Prices. What’s Next?
New Laws Take Aim at Drug Prices, But Stronger Action Needed
Drug Prices
New Laws Take Aim at Drug Prices, But Stronger Action Needed
After Sluggish Start, Is the Biosimilar Market Poised for Growth?
Drug Prices
After Sluggish Start, Is the Biosimilar Market Poised for Growth?
Drug Pricing Reform Enters a Big, New Battleground: States
Drug Prices
Drug Pricing Reform Enters a Big, New Battleground: States
How One Colorado Organization Brought Down Health Care Prices
Commercial Sector Prices
How One Colorado Organization Brought Down Health Care Prices
Landmark SCOTUS Ruling Opens the Door for Stronger State Regulation of PBMs
Drug Prices
Landmark SCOTUS Ruling Opens the Door for Stronger State Regulation of PBMs
A Drug is 90 Percent Effective at Preventing HIV. It Costs Up to $1,800 Per Month.
Drug Prices
A Drug is 90 Percent Effective at Preventing HIV. It Costs Up to $1,800 Per Month.
New Federal Reform Will Boost Organ Transplants, Saving Thousands of Lives
Organ Donation
New Federal Reform Will Boost Organ Transplants, Saving Thousands of Lives
About Us
We strive to maximize opportunity and minimize injustice by investing in systemic solutions that will outlast our funding.
- Criminal Justice
- Health
- Public Finance
- Higher Education & Career Pathways
- Infrastructure
- Evidence & Evaluation
